Literature DB >> 2110803

Calcium and phosphorus solubility in neonatal intravenous feeding solutions.

P MacMahon1, P D Mayne, M Blair, C Pope, I Z Kovar.   

Abstract

The limited solubility of calcium and phosphorus in standard parenteral nutrition formulations has restricted the ability to provide sufficient minerals to preterm infants to prevent substrate deficient metabolic bone disease. We determined the solubility limits of calcium and phosphorus in a total of 160 formulations under carefully controlled conditions. By increasing the concentrations of dextrose, amino acids, and by using Addiphos instead of 8.7% dipotassium hydrogen phosphate as the phosphorus source, higher concentrations of both calcium and phosphorus were held in solution. This should permit the delivery of increased concentrations of these minerals at rates which approximate fetal accretion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110803      PMCID: PMC1590152          DOI: 10.1136/adc.65.4_spec_no.352

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  Body composition of the reference fetus.

Authors:  E E Ziegler; A M O'Donnell; S E Nelson; S J Fomon
Journal:  Growth       Date:  1976-12

2.  Calcium and phosphate content of intravenous feeding regimens for very low birthweight infants.

Authors:  G Aiken; W Lenney
Journal:  Arch Dis Child       Date:  1986-05       Impact factor: 3.791

3.  Compatibility considerations in parenteral nutrient solutions.

Authors:  P W Niemiec; T W Vanderveen
Journal:  Am J Hosp Pharm       Date:  1984-05

4.  Metabolic bone disease in preterm infants.

Authors:  O G Brooke; A Lucas
Journal:  Arch Dis Child       Date:  1985-07       Impact factor: 3.791

5.  Compatibility of common additives in protein hydrolysate/dextrose solutions.

Authors:  N H Kobayashi; J C King
Journal:  Am J Hosp Pharm       Date:  1977-06

6.  Calcium and phosphorus compatibility in parental nutrition solutions for neonates.

Authors:  L D Eggert; W J Rusho; M W MacKay; G M Chan
Journal:  Am J Hosp Pharm       Date:  1982-01

7.  Calcium and phosphate requirements of preterm infants who require prolonged hyperalimentation.

Authors:  P J Knight; S Buchanan; H W Clatworthy
Journal:  JAMA       Date:  1980-03-28       Impact factor: 56.272

8.  Association of mineral composition of neonatal intravenous feeding solutions and metabolic bone disease of prematurity.

Authors:  P MacMahon; M E Blair; P Treweeke; I Z Kovar
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

9.  Etiologic factors in rickets of very low-birth-weight infants.

Authors:  J C Callenbach; M B Sheehan; S J Abramson; R T Hall
Journal:  J Pediatr       Date:  1981-05       Impact factor: 4.406

10.  Compatibility of calcium chloride and calcium gluconate with sodium phosphate in a mixed TPN solution.

Authors:  R S Henry; R W Jurgens; R Sturgeon; N Athanikar; A Welco; M Van Leuven
Journal:  Am J Hosp Pharm       Date:  1980-05
  10 in total
  4 in total

1.  Acid-base state of the preterm infant and the formulation of intravenous feeding solutions.

Authors:  P MacMahon; P D Mayne; M Blair; C Pope; I Z Kovar
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

2.  Sodium glycerophosphate in the treatment of neonatal hypophosphataemia.

Authors:  I Costello; C Powell; A F Williams
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-07       Impact factor: 5.747

3.  Calcium Chloride in Neonatal Parenteral Nutrition Solutions with and without Added Cysteine: Compatibility Studies Using Laser and Micro-Flow Imaging Methodology.

Authors:  Robert K Huston; J Mark Christensen; Sultan M Alshahrani; Sumeia M Mohamed; Sara M Clark; Jeffrey A Nason; Ying Xing Wu
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

4.  Influence of the calcium concentration in the presence of organic phosphorus on the physicochemical compatibility and stability of all-in-one admixtures for neonatal use.

Authors:  Daniela de Oliveira Ribeiro; Bianca Waruar Lobo; Nádia Maria Volpato; Venício Féo da Veiga; Lúcio Mendes Cabral; Valeria Pereira de Sousa
Journal:  Nutr J       Date:  2009-10-26       Impact factor: 3.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.